Skip to main content

Peer Review reports

From: Efficacy and safety of bupropion in cancer-related fatigue, a randomized double blind placebo controlled clinical trial

Original Submission
6 Sep 2019 Submitted Original manuscript
4 Oct 2019 Author responded Author comments - Ebrahim Salehifar
Resubmission - Version 2
4 Oct 2019 Submitted Manuscript version 2
11 Nov 2019 Reviewed Reviewer Report - Rodabe Amaria
26 Nov 2019 Reviewed Reviewer Report - Basudev Chowdhury
28 Nov 2019 Reviewed Reviewer Report - Charles Catton
20 Dec 2019 Author responded Author comments - Ebrahim Salehifar
Resubmission - Version 3
20 Dec 2019 Submitted Manuscript version 3
3 Jan 2020 Reviewed Reviewer Report - Charles Catton
21 Jan 2020 Reviewed Reviewer Report - Basudev Chowdhury
29 Jan 2020 Author responded Author comments - Ebrahim Salehifar
Resubmission - Version 4
29 Jan 2020 Submitted Manuscript version 4
31 Jan 2020 Author responded Author comments - Ebrahim Salehifar
Resubmission - Version 5
31 Jan 2020 Submitted Manuscript version 5
4 Feb 2020 Author responded Author comments - Ebrahim Salehifar
Resubmission - Version 6
4 Feb 2020 Submitted Manuscript version 6
Publishing
11 Feb 2020 Editorially accepted
27 Feb 2020 Article published 10.1186/s12885-020-6618-9

You can find further information about peer review here.

Back to article page